Defilade Capital Management, L.P.
Defilade Capital Management, L.P. reported 30 holdings worth US$599M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Defilade Capital Management, L.P. reported 30 holdings worth US$599M as of Sep 30, 2026. Largest: Pfizer, Inc., Eli Lilly and Company and BioMarin Pharmaceutical Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 30
- Value as reported
- US$599M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Pfizer, Inc. | 1.52M | US$43.5M | 7.3% |
| Eli Lilly and Company | 34,774 | US$40.2M | 6.7% |
| BioMarin Pharmaceutical Inc. | 602K | US$36.1M | 6.0% |
| Gilead Sciences, Inc. | 227K | US$33.8M | 5.6% |
| Axsome Therapeutics, Inc. | 175K | US$32.3M | 5.4% |
| Amgen Inc. | 74,079 | US$31.2M | 5.2% |
| ORIC Pharmaceuticals, Inc. | 2.27M | US$30.6M | 5.1% |
| Intuitive Surgical, Inc. | 71,860 | US$29.2M | 4.9% |
| Stryker Corporation | 81,524 | US$22.5M | 3.7% |
| Vera Therapeutics, Inc. | 652K | US$21.1M | 3.5% |
| Cogent Biosciences, Inc. | 632K | US$20.2M | 3.4% |
| Veeva Systems Inc. | 69,141 | US$19.7M | 3.3% |
| Agios Pharmaceuticals, Inc. | 570K | US$19M | 3.2% |
| Thermo Fisher Scientific Inc | 26,469 | US$17.9M | 3.0% |
| Ocular Therapeutix, Inc. | 2.28M | US$17.5M | 2.9% |
| Larimar Therapeutics, Inc. | 4.93M | US$15.8M | 2.6% |
| Boston Scientific Corporation | 351K | US$15.3M | 2.6% |
| Revolution Medicines, Inc. | 71,186 | US$14.6M | 2.4% |
| Solventum Corporation | 166K | US$14.6M | 2.4% |
| Envista Holdings Corporation | 534K | US$12.5M | 2.1% |
| Olema Pharmaceuticals, Inc. | 1.44M | US$12.4M | 2.1% |
| Evommune, Inc. | 1.43M | US$11.8M | 2.0% |
| Eledon Pharmaceuticals, Inc. | 3.53M | US$8.92M | 1.5% |
| ICU Medical, Inc. | 54,435 | US$8.74M | 1.5% |
| Enovis Corporation | 400K | US$7.3M | 1.2% |
| PACS Group, Inc. | 165K | US$6.86M | 1.1% |
| Black Diamond Therapeutics, Inc. | 1.77M | US$3.34M | 0.56% |
| Mereo BioPharma Group plc | 7.56M | US$3.04M | 0.51% |
| PTC Therapeutics, Inc. | 0 | US$0 | 0.00% |
| STAAR Surgical Company | 0 | US$0 | 0.00% |
| Teleflex Incorporated | 0 | US$0 | 0.00% |
| Tyra Biosciences, Inc. | 0 | US$0 | 0.00% |
| Zimmer Biomet Holdings, Inc. | 0 | US$0 | 0.00% |
| Abbott Laboratories | 0 | US$0 | 0.00% |
| Baxter International Inc. | 0 | US$0 | 0.00% |
| Crinetics Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Denali Therapeutics Inc. | 0 | US$0 | 0.00% |
| Elanco Animal Health Incorporated | 0 | US$0 | 0.00% |
| Glaukos Corporation | 0 | US$0 | 0.00% |
| Globus Medical, Inc. | 0 | US$0 | 0.00% |
| Insmed Incorporated | 0 | US$0 | 0.00% |
| Insulet Corporation | 0 | US$0 | 0.00% |
| Lantheus Holdings, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC
Related